Tonix CEO buys 5,000 TNXP shares in open market
Tonix Pharmaceuticals Holding Corp. Chief Executive Officer Seth Lederman reported an open-market purchase of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tonix Pharmaceuticals Holding Corp. Chief Executive Officer Seth Lederman reported an open-market purchase of common stock. On June 9, 2026, he bought 5,000 shares at a weighted average price of $11.79 per share in a series of trades priced between $11.735 and $11.883.
Following this purchase, Lederman directly owns 9,005 common shares. He also has indirect ownership of 1 share through Lederman & Co. and 20,001 shares through an IRA account, where he may be deemed a control person of the Lederman & Co. entity.
Insider Trade Summary
Net Buyer: 5,000 shares
Net Buy
3 txns
Insider
LEDERMAN SETH
Role
Chief Executive Officer
Bought
5,000 shs ($59K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, $0.001 par value | 5,000 | $11.79 | $59K |
| holding | Common Stock, $0.001 par value | -- | -- | -- |
| holding | Common Stock, $0.001 par value | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.001 par value — 9,005 shares (Direct);
Common Stock, $0.001 par value — 20,001 shares (Indirect, By IRA Account);
Common Stock, $0.001 par value — 1 shares (Indirect, Lederman & Co.)
Footnotes (2)
- F1. Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.735 to $11.883 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
- F2. Reporting Person may be deemed a control person of this entity.
Key Figures
Shares purchased: 5,000 shares
Weighted average price: $11.79 per share
Trade price range: $11.735–$11.883 per share
+3 more
6 metrics
Shares purchased
5,000 shares
Open-market buy on June 9, 2026
Weighted average price
$11.79 per share
Open-market purchase price
Trade price range
$11.735–$11.883 per share
Series of trades on transaction date
Direct holdings after transaction
9,005 shares
Common stock held directly by CEO
Indirect IRA holdings
20,001 shares
Common stock held through IRA account
Indirect Lederman & Co. holding
1 share
Held via Lederman & Co. entity
Key Terms
open market transaction, weighted average purchase price, indirect ownership, IRA Account, +1 more
5 terms
open market transaction financial
"Represents the weighted average purchase price of shares purchased in a series of open market transactions"
An open market transaction is a buy or sell of publicly traded securities executed on an exchange or other public trading venue where many buyers and sellers can participate. It matters to investors because these trades change the visible supply and demand for a stock—like shoppers moving prices in a busy marketplace—affecting share price, liquidity (how easily you can trade), and sometimes the balance of ownership.
weighted average purchase price financial
"Represents the weighted average purchase price of shares purchased in a series of open market transactions"
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
indirect ownership financial
"direct_or_indirect": "I", "nature_of_ownership": "Lederman & Co.""
IRA Account financial
""nature_of_ownership": "By IRA Account""
control person financial
"Reporting Person may be deemed a control person of this entity"
A control person is an individual or entity that can significantly influence a company’s decisions and direction through ownership, voting power, or contractual rights—think of them as the captain who can steer the ship. Investors care because a control person’s choices affect corporate strategy, board appointments, and transactions that can raise or lower a stock’s value, and they often carry additional legal responsibilities and disclosure requirements to protect other shareholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tonix Pharmaceuticals (TNXP) report for Seth Lederman?
Tonix Pharmaceuticals reported that CEO Seth Lederman bought 5,000 shares of common stock in the open market. The shares were acquired on June 9, 2026 at a weighted average price of $11.79 per share across multiple trades.
What indirect Tonix Pharmaceuticals holdings are associated with Seth Lederman?
The filing shows 1 Tonix share held indirectly through Lederman & Co. and 20,001 shares held indirectly through an IRA account. The reporting person may be deemed a control person of the Lederman & Co. entity, according to the disclosed footnote.
Was the Tonix Pharmaceuticals (TNXP) insider transaction an open-market buy or sale?
The reported Tonix Pharmaceuticals insider transaction was an open-market purchase, not a sale. CEO Seth Lederman acquired 5,000 common shares under transaction code P, which denotes an open-market or private purchase, increasing his direct share ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates